The store will not work correctly when cookies are disabled.
6-Chloro-N-(3-trifluoromethylphenyl)pyrazine-2-carboxamide
ID: ALA496348
PubChem CID: 24881735
Max Phase: Preclinical
Molecular Formula: C12H7ClF3N3O
Molecular Weight: 301.66
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1cccc(C(F)(F)F)c1)c1cncc(Cl)n1
Standard InChI: InChI=1S/C12H7ClF3N3O/c13-10-6-17-5-9(19-10)11(20)18-8-3-1-2-7(4-8)12(14,15)16/h1-6H,(H,18,20)
Standard InChI Key: VXNCEYUSHOKAAC-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 21 0 0 0 0 0 0 0 0999 V2000
12.2932 -10.0781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2920 -10.9054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0068 -11.3183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.7231 -10.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7202 -10.0745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0050 -9.6654 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4332 -9.6593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1491 -10.0691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.4300 -8.8344 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.8619 -9.6539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5763 -10.0672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2886 -9.6527 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2860 -8.8269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5650 -8.4174 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8556 -8.8341 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5787 -9.6658 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.0044 -10.0628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.7148 -10.4740 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.4161 -9.3480 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
17.5963 -10.7797 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8 10 1 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
1 16 1 0
7 8 1 0
12 17 1 0
17 18 1 0
7 9 2 0
17 19 1 0
4 5 1 0
17 20 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 301.66 | Molecular Weight (Monoisotopic): 301.0230 | AlogP: 3.40 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.43 | CX Basic pKa: ┄ | CX LogP: 2.72 | CX LogD: 2.72 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.92 | Np Likeness Score: -2.05 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |